Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged 2. Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Lin, Y. C., Lin, Y. C., Lin, F. Y., Shih, C. M., Wu, M. S., Chen, T-W., Chen, H. H., Chang, N. C., Tsao, N. W., & Huang, C. Y. (2014). Early continuous renal replacement therapy in cardiogenic shock patients with severe acute kidney injury undergoing extracorporeal membrane oxygenation. CardioRenal Medicine, 4(2), 130-139. https://doi.org/10.1159/000364835